Position in DERM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,289
+$8,779 QoQ
Shares Held
2,194
+1019.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FMR LLC holds $5,286,613,725 across 50 Drug Manufacturers - Specialty & Generic names. DERM ranks #44 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
50,925,366 | $1,218,644,005 | |
| 2 | HLN |
Haleon plc
|
113,969,159 | $1,140,831,280 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
33,132,795 | $997,959,784 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
4,626,453 | $350,916,458 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
6,823,700 | $328,561,152 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
528,346 | $313,298,609 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
16,630,541 | $231,164,518 | |
| 8 | VTRS |
Viatris Inc
|
16,588,514 | $224,110,822 |
All Filings in DERM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,289 | 2,194 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,510 | 196 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $135 | 19 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $11 | 2 | Shares | Defined | 2025-05-12 | |
| 2023-12-31 | $737 | 128 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||